View Section: Company Analysis
Advanced Oncotherapy Rating
R3
R3I1.F stock is not rated by Eyestock analysis.
The financial statements data is not enough to calculate the rating
Discover High-rated Companies
View Section: Valuation
R3
Last reporting period 30 Jun, 2022
Updated —
Last price
—
Market cap $B
0.013
Exchange
XFRA - Deutsche Boerse AG
R3
R3I1.F stock is not rated by Eyestock analysis.
The financial statements data is not enough to calculate the rating